VCM
PRCT icon

Versant Capital Management’s Procept Biorobotics PRCT Stock Holding History

Versant Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Buy
1,193
+1,084
+994% +$27.1K ﹤0.01% 1773
2026
Q1 		$2.73K Buy
+109
New +$3.07K ﹤0.01% 2511

Other funds holding PRCT

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
RAM
Robocap Asset Management London, United Kingdom $124M AUM 95% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
GITFIT
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) Warsaw, Poland $249M AUM 37.04% 1-Year Est. Return
KCM
KRS Capital Management Bloomfield, Michigan $215M AUM 69.3% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Enclave Advisors Austin, Texas $790M AUM 21.99% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Versant Capital Management's PRCT Position: Q2 2026 in Review

Versant Capital Management increased its Procept Biorobotics (PRCT) stake by 994% in Q2 2026, buying an estimated $27.1K and bringing the position to 1,193 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Versant Capital Management first reported a position in PRCT in Q1 2026 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Versant Capital Management held 1,193 shares of Procept Biorobotics worth $26.9K as of Q2 2026.
  • Versant Capital Management bought 1,084 Procept Biorobotics shares in Q2 2026, an estimated $27.1K.
  • Procept Biorobotics made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1773 holding.
  • Versant Capital Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.